» Articles » PMID: 39811675

Virtual Screening and Evaluation of Bioactive Peptides from As Potential HMGCR Inhibitors for Hyperlipidemia Treatment

Overview
Journal Front Nutr
Date 2025 Jan 15
PMID 39811675
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Hyperlipidemia remains a major disease threatening global public health. The morbidity and mortality associated with cardiovascular diseases have been increasing. The inhibition of 3-Hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR), a key enzyme in the cholesterol synthesis pathway, can effectively reduce cholesterol levels.

Methods And Results: In this study, the most suitable protease for preparing HMGCR inhibitory peptides was screened using the evaluation indexes of peptide yield and HMGCR inhibition rate. Peptide sequences with molecular weights <1 kDa were identified, and peptide fragments were docked with HMGCR for virtual screening. The inhibitory effects of these peptides on HMGCR activity were evaluated using a high-fat Hep-G2 cell model. The screened peptides possessed significant HMGCR inhibitory activity and reduced cholesterol micelle solubility and total cholesterol and triglyceride levels in hyperlipidemic Hep-G2 cells.

Conclusion: This study provides novel insights into developing natural drugs for hyperlipidemia; moreover, the results will facilitate the functional application of marine bioactive peptides.

References
1.
Gesto D, Pereira C, Cerqueira N, Sousa S . An Atomic-Level Perspective of HMG-CoA-Reductase: The Target Enzyme to Treat Hypercholesterolemia. Molecules. 2020; 25(17). PMC: 7503714. DOI: 10.3390/molecules25173891. View

2.
Mutha R, Tatiya A, Surana S . Flavonoids as natural phenolic compounds and their role in therapeutics: an overview. Futur J Pharm Sci. 2021; 7(1):25. PMC: 7816146. DOI: 10.1186/s43094-020-00161-8. View

3.
Sankar J, Rathinavel A, Mohammed Sadullah S, Devaraj S . Oligomeric proanthocyanidins mitigate cholesterol and cholic acid diet-induced hepatic dysfunction in male Sprague Dawley rats. J Biochem Mol Toxicol. 2018; :e22234. DOI: 10.1002/jbt.22234. View

4.
Liu L, Chen Y, Chen B, Xu M, Liu S, Su Y . Advances in Research on Marine-Derived Lipid-Lowering Active Substances and Their Molecular Mechanisms. Nutrients. 2023; 15(24). PMC: 10745522. DOI: 10.3390/nu15245118. View

5.
Neutra M, Kozlowski P . Mucosal vaccines: the promise and the challenge. Nat Rev Immunol. 2006; 6(2):148-58. DOI: 10.1038/nri1777. View